Login / Signup

Effect of Clarithromycin, a Strong CYP3A and P-glycoprotein Inhibitor, on the Pharmacokinetics of Edoxaban in Healthy Volunteers and the Evaluation of the Drug Interaction with Other Oral Factor Xa Inhibitors by a Microdose Cocktail Approach.

Alexander LenardSimon A HermannFelicitas StollJuergen BurhenneKathrin I FoersterGerd MikusAndreas D MeidWalter E HaefeliAntje Blank
Published in: Cardiovascular drugs and therapy (2023)
EudraCT Number: 2018-002490-22.
Keyphrases
  • helicobacter pylori
  • venous thromboembolism
  • helicobacter pylori infection
  • adverse drug
  • drug induced
  • emergency department